Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques

⁹⁰Y radioembolization is an increasingly used treatment for both primary and metastatic malignancy in the liver. Understanding the biophysical properties, dosing concerns, and imaging appearance of this treatment is important for interventional radiologists and nuclear medicine physicians to provide important therapy. ⁹⁰Y radioembolization is efficacious and safe, although the possibility of complications does exist. This article provides a comprehensive in-depth discussion about the indications for ⁹⁰Y radioembolization, reviews the role of preprocedural angiography and ^99mTc-macroaggregated albumin scans, illustrates different dosing techniques, compares and contrasts resin and glass microspheres, and describes potential complications.